TOP STORIES

• ORGANIZATION Indicators Needed to Frame Pharma as Growth Market in Japan, Says JPMA Policy Chief
  August 29, 2025

• REGULATORY Japan to Expand List of “Stable Supply Medicines” to 759 APIs, Adding Vaccines and Blood Products
  August 28, 2025

• COMMENTARY Pharmacies Reel from Pricey Drug Waste, Sparking Calls for Packaging Overhaul and Price Penalties
  August 27, 2025

• REGULATORY MHLW Pharma Bureau Seeks FY2026 Budget to Bolster PMDA and Speed Up SaMD Reviews
  August 27, 2025

• REGULATORY MHLW Seeks New R&D Tax Credit Scheme for Strategic Technologies in FY2026 Proposal
  August 27, 2025

• REGULATORY Japan Approves 3 New Drugs, Expands Label for Enhertu, Silgard 9 and More
  August 26, 2025

• BUSINESS Meiji Revives Penicillin Raw Material Production in Japan after 31 Years, Races to Pass Down Know-How
  August 26, 2025

• BUSINESS Astellas CFO Outlines Cost Cuts, Licensing Push as Xtandi Nears Patent Cliff
  August 25, 2025

• REGULATORY Novartis’ Radioligand Therapy, More Meds Inch Closer to Japan Approval with Panel OK
  August 25, 2025

• REGULATORY PMDA’s “Early Considerations” Start to Pay Off with Faster Reviews
  August 22, 2025

• REGULATORY Japan Mulls Preferential R&D Tax Credits for Strategic Technologies in FY2026 Reform Talks
  August 22, 2025

• ORGANIZATION Hemp Cannabinoid Consortium Draws 40 Inquiries from Industry and Academia
  August 22, 2025

• BUSINESS Linepharma Japan Eyes Ophthalmology as Second Pillar to Women’s Health
  August 22, 2025

• REGULATORY AMED to Put Practicality First in Project Selection: Ecosystem Coordinator
  August 21, 2025

• BUSINESS Itochu Launches J-STEP to Help Overseas Drug Makers Tackle Japan’s “Drug Loss”
  August 21, 2025

• BUSINESS Alloy Japan Looks to Turn iCAR-T into Shared Infrastructure, IND Filing Slated for 2026
  August 20, 2025

• BUSINESS Keytruda Retains Top Spot in Japan Drug Market in April-June: IQVIA
  August 20, 2025

• REGULATORY Japan Weighs Legal Framework for Pharmaceutical Data Protection; JPMA Sees Opportunity for Reform
  August 19, 2025

• REGULATORY Japan Approves First SGLT2 Generics, 12 Firms Pile into Vimpat Ahead of December Listing
  August 18, 2025

• REGULATORY Novartis’ Radioligand Therapy, Other New Meds Up for Japan Panel Review on Aug. 22
  August 12, 2025

ページ

• « 先頭
• ‹ Prev
• …
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• …
• Next ›
• 最終 »